Alyeska Investment Group, L.P.

Position in JNJ — Johnson & Johnson

CIK 1453072 CHICAGO, IL

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$204,032,112

+$9,832,509 QoQ

Shares Held

834,692

-11.1% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $1,016,752,962 across 7 Drug Manufacturers - General names. JNJ ranks #3 (20.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	2,305,574	$277,337,496
2	AZN	Astrazeneca PLC	1,062,278	$209,502,467
3	JNJ	Johnson & Johnson This page	834,692	$204,032,112
4	BIIB	Biogen Inc.	805,050	$147,589,816
5	SNY	Sanofi	2,306,229	$111,114,113
6	GSK	GSK plc	1,210,746	$66,821,071
7	NVO	Novo Nordisk A S	9,684	$355,887

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$204,032,112	834,692	-11.1%	Shares	Sole	2026-05-15
2025-12-31	$194,199,603	938,389	+25.9%	Shares	Sole	2026-02-13
2025-09-30	$138,197,048	745,319	+37.4%	Shares	Sole	2025-11-17
2025-06-30	$82,873,137	542,541	+305.7%	Shares	Sole	2025-08-14
2025-03-31	$22,177,285	133,727	-84.0%	Shares	Sole	2025-05-15
2024-12-31	$120,623,058	834,069	+14.0%	Shares	Sole	2025-02-14
2024-09-30	$118,597,776	731,814	+71.8%	Shares	Sole	2024-11-14
2024-06-30	$62,268,252	426,028	-30.7%	Shares	Sole	2024-08-14
2024-03-31	$97,286,850	615,000	+61.8%	Shares	Sole	2024-05-15
2023-12-31	$59,561,200	380,000	+2539.3%	Shares	Sole	2024-02-14
2020-03-31	$1,888,009	14,398	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.